Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
EMAT heads toward its November 17 earnings date with a borrow market that has barely recovered from last week's seizure, a short position still expanding, and a stock down 54% in a month.
The lending picture has shifted only marginally since the earlier note flagged the collapse in availability. At 2.4%, availability remains near the tightest level of the past year, with the 52-week floor at 0.18% still uncomfortably close. Cost to borrow held at 76.6% on October 13, more than double where it was a week prior and roughly 60 percentage points above where it sat through most of September and early October. The sharp move on October 13 was not a one-day glitch: the rate had been edging higher through the week before the step-change, and it has not pulled back. Anyone seeking to build a new short position now pays a premium that would have looked extreme a month ago.
Short interest is still growing despite those costs. ORTEX's daily estimate rose 8.1% in a single session to 3.06 million shares, and the month-on-month build is 377%. That kind of sustained accumulation into tightening borrow conditions points to strong conviction on the bearish side, not opportunistic trading. The ORTEX short score of 65.4 is consistent with that read: elevated, and broadly stable over the past two weeks, suggesting the negative thesis has not materially changed even as the stock has kept falling. The combined score of 67.9 offers no obvious counter-signal from the broader scoring framework.
The ownership structure limits the pool of freely tradeable shares and amplifies the dynamics above. Three individuals, William Wilcox, Nicole Garcia and Andrew Knaggs, together hold roughly 86% of outstanding shares, leaving a thin float for both longs and shorts to operate in. Garcia trimmed 1.7 million shares as of September 4, the only insider transaction of note in the disclosed period. Among institutional holders, the positions outside the top three are small: Osaic Wealth holds around 1.2% and Charles Schwab Investment Management added a full position in October, but these are passive flows rather than signals of conviction. The Russell 2000 addition completed in September, with roughly $79 million in index-tracker buying executed around the September 18 to 21 rebalance window, that flow is now fully in the rear-view mirror and no longer a support.
The analyst picture is thin and dated. Two Buy initiations are on record, from Litchfield Hills in June 2026 at a $12 target and from Clear Street in February at $30. With the stock at $1.43 and those targets reflecting coverage initiated at very different price levels, they carry limited weight against current conditions. The Street has not updated since mid-September.
Earnings have historically produced large swings at EMAT. The August 20 print generated a 39% one-day move. The May 22 result moved the stock 14% lower the next day and nearly 19% lower over five days. The next event is scheduled for November 17, with a borrow that remains near fully allocated and a short position still at a multi-month high, the setup into that release looks more charged than the underlying business news alone would normally justify.
What to watch now is whether availability recovers at all before November 17, and whether short interest peaks or keeps building through October.
See the live data behind this article on ORTEX.
Open EMAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
